Skip to content Skip to footer
Subscribe Now
Vaccines Based Top 20 2022
TOP 20

Top 20 Vaccines Based on 2022 Total Revenue

Shots:Driven by a noble pursuit to ensure global health security, vaccines cater to the healthcare needs of millions and billions of people. With an instrumental role in containing the COVID-19 pandemic, immunization prevents more than 5 million deaths annually from conditions like diphtheria, tetanus, pertussis, influenza, and measlesWith a global market size of…
July 25, 2023

Read more

Innovative Digital Therapeutics Top 20 2022
TOP 20

Top Innovative Digital Therapeutics Companies of 2022

Shots:Transforming lives by leveraging cutting-edge technological advances, digital health companies have embarked on a journey to reshape the way we see and experience therapeuticsDigital health companies are fostering the use of highly innovative technologies in the healthcare system. In 2021, the global digital health therapeutics market was valued at $3.8B and is envisioned…
July 12, 2023

Read more

Medical Device Top 20 2022
TOP 20

Top 20 Medical Device Companies Based on 2022 Total Revenue

Shots:Driven by constant innovation and life-changing technological advances, medical device companies have integrated a holistic approach to diagnosis and therapeutics. Bolstered by the inch-perfect result and cutting-edge technology, gradually medical devices have got profoundly embedded in our livesWith a global market value of $562.6B in 2022, medical device companies are anticipated to touch…
May 10, 2023

Read more

RNAi Therapeutic Top 20 2022
TOP 20

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

Shots:RNAi Therapeutic leverages the biological response of degrading (mRNA) before it gets translated into a protein. By using short double-stranded RNA in silencing a targeted disease-causing mutation, researchers are working steadfastly in multiple indications to expand RNAi therapeuticRNAi therapy comes to the rescue when targeting a specific protein gets difficult using a conventional…
April 25, 2023

Read more

Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value
TOP 20

Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value

Shots:Post M&A deals, companies often cannot sail through a few key aspects of the partnership, such as limited ownership, exorbitant recovery costs, and poor integration process, leading to deal terminations. The improperly executed expansion program also contributes significantly to the failed partnershipTo tackle such scenarios, companies are cautious enough to make backup plans beforehand…
March 22, 2023

Read more

Load more